Erik Korevaar

If you made any changes in Pure these will be visible here soon.

Feasibility of dose escalation for NSCLC using IMPT
Arno Hessels (Speaker), Sabine Visser (Contributor), Stefan Both (Contributor), Erik Korevaar (Contributor), Johannes Albertus Langendijk (Contributor) & Robin Wijsman (Contributor)
29-Jun-2022 → 1-Jul-2022
Activity: Talk and presentation › Academic presentation › Academic
Cancers (Journal)
Arjen van der Schaaf (Guest editor) & Erik Korevaar (Guest editor)
2021 → 2022
Activity: Peer-review and editorial work › Editorial work › Academic

Activities